Table 1.

In vitro profile of kinases inhibitors against H1299 and H2087 cells. The assays were performed in three independent experiments

Kinases inhibitor	Cell lines	IC50 (nM)
Gefitinib	H1299	> 100 ± 9.7
	H2087	> 100 ± 3.2
Regorafenib	H1299	31 ± 0.2
	H2087	24 ± 4.0
Crizotinib	H1299	59 ± 1.7
	H2087	53 ± 2.2
Dabrafenib	H1299	67 ± 3.2
	H2087	59 ± 4.5
Ceritinib	H1299	52 ± 3.1
	H2087	60 ± 6.0
Trametinib	H1299	12 ± 1.4
	H2087	8 ± 2.6